Skip to Content

Levothyroxine Sodium Injection

Last Updated: June 24, 2014
Status: Resolved

Products Affected - Description

Levothyroxine sodium lyophilized powder for injection

Reason for the Shortage

  • Fresenius Kabi (formerly APP) could not provide a reason for the shortage of the 500 mcg vial.
  • Fresenius Kabi (formerly APP) launched levothyroxine 200 mcg vials in mid-2013.

Available Products

Levothyroxine sodium lyophilized powder for injection, Fresenius Kabi (formerly APP)
100 mcg vial (NDC 63323-0649-07)

200 mcg vial (NDC 63323-0647-10)
500 mcg vial (NDC 63323-0648-10)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

June 24, 2014; May 19, 2014; April 2, 2014; March 3, 2014; February 14, 2014; December 4, 2013; September 16, 2013; July 17, 2013; May 30, 2013; April 17, 2013; April 12, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide